Abliva AB (publ)
NEVPF · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.13 | 0.07 | -0.07 | 0.06 |
| FCF Yield | -2.79% | -29.33% | -19.55% | -23.25% |
| EV / EBITDA | -18.04 | -4.26 | -3.49 | -4.70 |
| Quality | ||||
| ROIC | -44.16% | -22.62% | -38.05% | -35.73% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.50 | 1.87 | 1.00 | 1.45 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | 20.14% | 0.99% | -3.19% |
| Free Cash Flow Growth | 62.65% | -44.09% | 1.65% | -3,649.43% |
| Safety | ||||
| Net Debt / EBITDA | 1.26 | 2.46 | 1.78 | 1.74 |
| Interest Coverage | -2,724.30 | -1,655.08 | -1,979.85 | -1,357.71 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -313.53 | -927.09 |